Skip to main content
Premium Trial:

Request an Annual Quote

The Outsourcing of Drugs

The Indian pharmaceutical sector "was once notorious for making cheap knockoffs of Western medicines" to sell in developing countries, says the New York Times, but now it is a manufacturing center of drugs to sell worldwide. "What I see happening now is manufacturing and even packaging and even formulation are moving to India," says Jim Worrell, the chief executive of Pharma Services Network.

There still are, however, questions about knock-off and counterfeit drugs, and FDA has opened an office in Mumbai and one in Delhi to "verify that important products and the way they are manufactured meet US health and safety requirements," a FDA spokesperson tells the Times.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.